Debt-to-equity of Acumen Pharmaceuticals, Inc. from 31 Mar 2022 to 30 Sep 2025

Taxonomy & unit: ratio: %
Description: Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary: Acumen Pharmaceuticals, Inc. quarterly Debt-to-equity in % history and change rate from 31 Mar 2022 to 30 Sep 2025.
Acumen Pharmaceuticals, Inc. Debt-to-equity for the quarter ending 30 Sep 2025 was 38%, a 115% increase year-over-year.

Debt-to-equity, Quarterly (%)

Debt-to-equity, YoY Quarterly Change (%)

Acumen Pharmaceuticals, Inc. Quarterly Debt-to-equity (%)

Period	Value	YoY Chg	Change %	Date
Q3 2025	38%	+20%	+115%	30 Sep 2025
Q2 2025	31%	+19%	+148%	30 Jun 2025
Q1 2025	25%	+15%	+154%	31 Mar 2025
Q4 2024	21%	+14%	+184%	31 Dec 2024
Q3 2024	18%	+14%	+367%	30 Sep 2024
Q2 2024	13%	+8%	+192%	30 Jun 2024
Q1 2024	10%	+6%	+169%	31 Mar 2024
Q4 2023	7%	+5%	+155%	31 Dec 2023
Q3 2023	4%	+1%	+54%	30 Sep 2023
Q2 2023	4%	+3%	+141%	30 Jun 2023
Q1 2023	4%	+1%	+38%	31 Mar 2023
Q4 2022	3%			31 Dec 2022
Q3 2022	2%			30 Sep 2022
Q2 2022	2%			30 Jun 2022
Q1 2022	3%			31 Mar 2022

* An asterisk sign (*) next to the value indicates that the value is likely invalid.